Laurus Labs Limited
LAURUSLABS

Laurus Labs Limited

Healthcare
Share price
₹2,295
Market cap
₹1.2L Cr
1Y return
▲ 133%

A research-driven pharmaceutical and biotechnology company specializing in Active Pharmaceutical Ingredients for anti-retroviral, oncology, cardiovascular, and gastroenterology therapies with global leadership positions in select segments. Laurus Labs operates multiple facilities approved by major regulatory agencies including USFDA, WHO-Geneva, EMA, and others. The company provides integrated contract manufacturing and development services to international pharmaceutical innovators across clinical development through commercial production stages.

Investors holding Laurus Labs Limited

5.79%
4.02%
1.32%
1.07%

Recent moves 7

1newest move
Members only

Including 1 exit

Unlock this move
SBI Life InsuranceNew position
SBI Life Insurance now holds a 1.07% stake in Laurus Labs Limited, up from under 1% in the previous quarter, with a holding of 57,90,000 shares.
21 Oct 2026
Read more
American Funds (Capital Group)Decreased
American Funds (Capital Group) cut its stake in Laurus Labs from 7.05% to 5.79%, selling 67,80,688 shares.
21 Oct 2026
Read more
Mirae Asset Mutual FundDecreased
Mirae Asset Mutual Fund decreased its stake in Laurus Labs from 4.33% to 4.02%, selling 16,86,780 shares.
21 Oct 2026
Read more
Kotak OffshoreDecreased
Kotak Offshore decreased its stake in Laurus Labs, selling 297,109 shares and reducing its holding from 1.06% to 1.01%.
22 Jul 2026
Read more
American Funds (Capital Group)Decreased
American Funds (Capital Group) decreased its stake in Laurus Labs from 8.15% to 7.05%, selling 5,988,473 shares.
22 Jul 2026
Read more
Mirae Asset Mutual FundDecreased
Mirae Asset Mutual Fund decreased its stake in Laurus Labs Limited from 4.47% to 4.33% by reducing its shareholding from 24,110,341 to 23,387,661 shares.
22 Jul 2026
Read more

Track the whales in Laurus Labs Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1